◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › S › SBS

Stratec SE (SBS) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Devices · DATA UPDATED 2026-08-16

Stratec SE (SBS) operates in the Medical Devices industry and is headquartered in Birkenfeld, Germany with about 1,395 employees. Its market capitalization is roughly €267 million. In the fiscal year ended 2025-12-31, SBS reported €251M in revenue and (€0M) in net income.

Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers.

Interactive charts & full statements →

SBS Revenue & Earnings History — Annual Income Statement

Income statement	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Revenue	€251M	€258M	€270M	€275M	—
Gross Profit	€64M	€76M	€68M	€80M	—
Operating Income (EBIT)	€11M	€28M	€29M	€43M	—
Net Income	(€0M)	€16M	€15M	€29M	—

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SBS Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Total Revenue	€53M	€75M	€57M	€58M	€60M
Gross Profit	€10M	€19M	€13M	€16M	€16M
Operating Income (EBIT)	€0M	€1M	€4M	€2M	€3M
Net Income	(€2M)	(€4M)	€2M	€1M	€1M

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SBS Free Cash Flow History

Cash flow	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Dividends Paid	(€7M)	(€7M)	(€12M)	(€12M)	—

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SBS Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Dividends Paid	—	€0M	€0M	—	—	€0M

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SBS Balance Sheet History

Balance sheet	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Assets	€426M	€445M	€451M	€384M	—
Total Liabilities	€189M	€202M	€214M	€157M	—

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SBS viewer.

Other Companies in Medical Devices

TMCI · Treace Medical Concepts, Inc. — $309 million
2297 · Rainmed Medical Limited — $291 million
LAB · Standard BioTools Inc. — $280 million
SENS · Senseonics Holdings, Inc. — $270 million
PROF · Profound Medical Corp. — $267 million
RXST · RxSight, Inc. — $260 million
RCEL · AVITA Medical, Inc. — $254 million
STIM · Neuronetics, Inc. — $222 million

← SBRY All “S” companies SBSI →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.